5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
Current non-invasive tumor biomarkers failed to accurately identify patients with colorectal cancer (CRC), delaying CRC diagnosis and thus leading to poor prognosis. Dysregulation of 5-Methylcytosine (m5C) RNA has gradually been reported in various cancers, but their role in tumor diagnosis is rarel...
Main Authors: | Haofan Yin, Zhijian Huang, Shiqiong Niu, Liang Ming, Hongbo Jiang, Liang Gu, Weibin Huang, Jinye Xie, Yulong He, Changhua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.967921/full |
Similar Items
-
UHRF2 regulates local 5-methylcytosine and suppresses spontaneous seizures
by: Yidan Liu, et al.
Published: (2017-07-01) -
m5CRegpred: Epitranscriptome Target Prediction of 5-Methylcytosine (m5C) Regulators Based on Sequencing Features
by: Zhizhou He, et al.
Published: (2022-04-01) -
5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues
by: Adelaida Hernaiz, et al.
Published: (2023-01-01) -
5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer
by: Marion Turpin, et al.
Published: (2022-08-01) -
Characterization of 5-methylcytosine and 5-hydroxymethylcytosine in human placenta cell types across gestation
by: Rebecca L. Wilson, et al.
Published: (2019-07-01)